CTLA4 and breast carcinoma: In a recent study, Terranova et al. demonstrated that the exhausted CD8 cell phenotype, CD8+/PD-1+/CTLA-4+, and depletion of CD4+/FOXP3+/CTLA-4+ implicate a better response to ICIs in HR+ breast cancer [126].